Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-16

Clinical Trial Update: Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children [Phase 2]

View source ↗

Summary

Phase 2 trial updating nimotuzumab in combination with radio-chemotherapy for childhood brainstem neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Childhood Brain Stem Neoplasm | Phase 2 | Status: UNKNOWN